First Horizon Corporation’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Horizon Corporation’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.4K	Sell	15 -3	-17%	-$851	﹤0.01%	1256
2026 Q1	$5.02K	Sell	18 -200	-92%	-$57.6K	﹤0.01%	1159
2025 Q4	$66.1K	Sell	218 -26	-11%	-$8.11K	﹤0.01%	604
2025 Q3	$68.4K	Buy	+244	New	+$66.4K	﹤0.01%	547
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	985
2021 Q1	$1K	Hold	2	–	–	﹤0.01%	966
2020 Q4	$1K	Buy	+2	New	+$1.14K	﹤0.01%	959
2013 Q2	$22K	Buy	+200	New	+$23.5K	0.01%	388

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

First Horizon Corporation's BIO Position: Q2 2026 in Review

First Horizon Corporation reduced its Bio-Rad Laboratories Class A (BIO) stake by 17% in Q2 2026, selling an estimated $851 and leaving 15 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

First Horizon Corporation first reported a position in BIO in Q2 2013 and has held it in 8 quarters since. The position peaked at $68.4K in Q3 2025. 115 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

First Horizon Corporation held 15 shares of Bio-Rad Laboratories Class A worth $4.4K as of Q2 2026.
First Horizon Corporation sold 3 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $851.
Bio-Rad Laboratories Class A made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1256 holding.
First Horizon Corporation first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 8 quarters since.
First Horizon Corporation's Bio-Rad Laboratories Class A position peaked at $68.4K in Q3 2025.
115 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.